SIREN : 524139037
PARSYS TELEMEDECINE is a French company founded 15 years ago, specialized in the sector Programmation informatique. Based in VINCENNES (94300), this company of category PME shows in 2022 a revenue of 3.1 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-09
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2022 | 2021 | 2020 | 2019 | 2017 |
|---|---|---|---|---|---|
| Revenue | 3 077 136 € | N/C | N/C | N/C | N/C |
| Net income | 19 941 € | -22 744 € | 213 508 € | -1 715 355 € | 177 425 € |
| EBITDA | 858 356 € | N/C | N/C | N/C | N/C |
| Net margin | 0.6% | N/C | N/C | N/C | N/C |
In 2022, PARSYS TELEMEDECINE achieves revenue of 3.1 M€. After deducting consumption (716 k€), gross margin stands at 2.4 M€, i.e. a rate of 77%. This ratio measures the ability to generate value from commercial activity. EBITDA (= Gross margin - Personnel expenses - Taxes) reaches 858 k€, representing 27.9% of revenue. This high EBITDA margin provides strong self-financing capacity and resilience to uncertainties. Ultimately, net income (= EBIT +/- financial result +/- exceptional - corporate tax) amounts to 20 k€, i.e. 0.6% of revenue. This profit can be retained or distributed to shareholders.
3 077 136 €
2 361 168 €
858 356 €
-215 440 €
19 941 €
27.0%
The debt ratio (= Financial debt / Equity x 100) stands at 165%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 25%. The balance between equity and debt is satisfactory. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 2.3 years of cash flow to repay all financial debt. This short period demonstrates excellent debt sustainability. Cash flow represents 37.1% of revenue. Cash flow measures resources generated by operations, available for investment and debt repayment. This high level provides strong self-financing capacity.
164.851%
24.805%
37.12%
2.254
36.0%
In 2022, the debt ratio of PARSYS TELEMEDECINE (164.85) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2022, the financial autonomy of PARSYS TELEMEDECINE (24.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
In 2022, the repayment capacity of PARSYS TELEMEDECINE (2.25) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
The liquidity ratio (= Current assets / Current liabilities) stands at 121.15. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months. The interest coverage ratio (= EBIT / Interest expenses) is 21.5x. Operating income very largely covers interest expenses: high safety margin.
121.151
21.519
In 2022, the liquidity ratio of PARSYS TELEMEDECINE (121.15) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
In 2022, the interest coverage of PARSYS TELEMEDECINE (21.5x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 34 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 90 days. Excellent situation: suppliers finance 56 days of the operating cycle (retail model). Inventory turnover is 136 days (= Average inventory / Cost of goods x 360). This high level ties up cash and potentially creates obsolescence risk. Overall, WCR represents 54 days of revenue, i.e. 458 k€ to permanently finance.
457 539 €
34 j
90 j
136 j
54 j
Based on 120 transactions of similar company sales (all years), the value of PARSYS TELEMEDECINE is estimated at 1 213 691 € (range 559 587€ - 3 262 272€). With an EBITDA of 858 356€, the sector multiple of 2.2x is applied. The price/revenue ratio is 0.27x (conservative valuation). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Ajustez les pondérations selon votre analyse
This estimate is based on the analysis of 120 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare PARSYS TELEMEDECINE with other companies in the same sector:
Voir toutes les statistiques du secteur Programmation informatique
The revenue of PARSYS TELEMEDECINE in 2022 is 3.1 M€.
Yes, PARSYS TELEMEDECINE generated a net profit of 20 k€ in 2022.
The headquarters of PARSYS TELEMEDECINE is located in VINCENNES (94300), in the department Val-de-Marne.
The tax return of PARSYS TELEMEDECINE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
PARSYS TELEMEDECINE operates in the sector Programmation informatique (NAF code 62.01Z). See the 'Sector positioning' section above to compare the company with its competitors.